Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
5,335,435
-
Shares change
-
+573,302
-
Total reported value, excl. options
-
$114,593,901
-
Value change
-
+$11,356,856
-
Put/Call ratio
-
98%
-
Number of buys
-
37
-
Number of sells
-
-30
-
Price
-
$21.48
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q3 2014
88 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q3 2014.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,335,435 shares
of 27,795,576 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (793,000 shares), VANGUARD GROUP INC (757,693 shares), BlackRock Fund Advisors (488,328 shares), State Street Corp (314,395 shares), Wood Investment Counsel LLC (276,549 shares), NORTHERN TRUST CORP (266,458 shares), Miura Global Management, LLC (250,000 shares), BlackRock Institutional Trust Company, N.A. (243,689 shares), Selkirk Management LLC (165,700 shares), and GEODE CAPITAL MANAGEMENT, LLC (157,548 shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.